Skip to main content
. 2020 Dec 8;9(12):3978. doi: 10.3390/jcm9123978

Table 3.

IOP lowering effects of inhaled cannabinoids.

Authors Study Population Intervention Results
Hepler et al., 1971 [4] 11 healthy subjects 18 mg delta-9-THC 24% IOP lowering
(limited data available)
Flom et al., 1975 [20] 15 healthy subjects 12 mg delta-9-THC 13% IOP lowering after 80 min from administration
Hepler et al., 1976 [56] 136 subjects affected by POAG administered with 1, 2, or 4% THC cigarette 20 mg delta-9-THC
(2 g marijuana cigarette with 1% delta-9-THC)
29% and 22% IOP lowering after 30 and 180 min from administration
40 mg delta-9-THC
(2 g marijuana cigarette with 2% delta-9-THC)
25% and 17% IOP lowering after 30 and 180 min from administration
80 mg delta-9-THC
(2 g marijuana cigarette with 4% delta-9-THC)
34% and 22% IOP lowering after 30 and 180 min from administration
Hepler et al., 1976 [57] 40 healthy subjects 1% natural delta-9-THC cigarette 30% IOP lowering 30 min after administration
2% natural delta-9-THC cigarette 25% IOP lowering 30 min after administration
4% natural delta-9-THC cigarette 34% IOP lowering min after administration
1% synthetic delta-9-THC cigarette 15% IOP lowering 30 min after administration
2% synthetic delta-9-THC cigarette 23% IOP lowering 30 min after administration
4% synthetic delta-9-THC cigarette 24% IOP lowering 30 min after administration
Merritt et al., 1980 [65] 18 glaucoma patients (12 affected by POAG, 6 affected by secondary glaucoma) 18 mg delta-9-THC
(0.9 g marijuana cigarette with 2% delta-9-THC)
14.5% and 23.4% IOP lowering after 30 and 90 min from administration

(POAG: primary open angle glaucoma, IOP intraocular pressure, THC Tetrahydrocannabinol.).